Jerry N Ellis insider trades: Sciele Pharma (SCRX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jerry reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 23, 2008 | SCRX | ↓ Sell | 3,750 | $21.08 | $79K | Direct | May 28, 2008 (5d) |
| Sep 5, 2007 | SCRX | ↓ Sell | 6,625 | $25.92 | $172K | Direct | Sep 7, 2007 (2d) |
| Nov 15, 2006 | SCRX | ↓ Sell | 6,000 | $22.91 | $137K | Direct | Nov 17, 2006 (2d) |
| Aug 2, 2006 | SCRX | ↓ Sell | 625 | $20.12 | $13K | Direct | Aug 2, 2006 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Jerry N Ellis's insider trades
Jerry N Ellis is a director at Sciele Pharma (SCRX). Since Aug 2, 2006, Jerry has reported no open-market purchases and 4 sales worth $401K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (10 filings), option exercises (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SCRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.